Skip to main content
Equibles

Joshua Corson

Analyst

Senior Equity Research Associate, H.C. Wainwright

Equibles does not estimate personal net worth.

About Joshua Corson

Joshua Corson is recorded as Analyst at Senior Equity Research Associate, H.C. Wainwright. Joshua Corson has spoken on 2 investor events across 2 companies, most recently for Fennec Pharmaceuticals Inc. on September 15, 2026. Those appearances were for Fennec Pharmaceuticals Inc. (FENC) and Pharming Group N.V. (PHAR). The companies whose calls Joshua Corson spoke on are classified in the Healthcare sector.

Joshua Corson on recent calls

“And thank you for joining the H.C. Wainwright 28th Annual Global Investment Conference. My name is Joshua Corson, and I'm a Senior Equity Research Associate. Today, I would like to introduce our presenter, Robert Andrade, who is the CFO of Fennick Pharmaceuticals.”
Analyst — Senior Equity Research Associate, H.C. Wainwright, H.C. Wainwright 28th Annual Global Investment Conference ·
“Good morning, everyone, and thank you for joining me at the H.C. Wainwright 28th Annual Global Investment Conference. My name is Joshua Corson, and I'm a Senior Equity Research Associate.”
Analyst — Senior Equity Research Associate, H.C. Wainwright, H.C. Wainwright 28th Annual Global Investment Conference ·

Affiliation history

  • Senior Equity Research Associate, H.C. Wainwright

    Analyst

    Transcript header (unverified)

    Current

Company network

Recent activity